FITY (Fifty 1 Labs) Cash Flow for Lease Financing: $ Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Fifty 1 Labs Cash Flow for Lease Financing?

Fifty 1 Labs FITY -50.00% Cash Flow for Lease Financing is $ Mil as of Mar. 2026.

Fifty 1 Labs's Cash Flow for Lease Financing for the three months ended in Mar. 2026 was $ Mil. Fifty 1 Labs's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2026 was $ Mil.

Compared with last quarter ($ Mil in Dec. 2025 ), Fifty 1 Labs's Cash Flow for Lease Financing remained the same in Mar. 2026 ($ Mil).


Fifty 1 Labs Cash Flow for Lease Financing Historical Data

* Premium members only.

The historical data trend for Fifty 1 Labs's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fifty 1 Labs Cash Flow for Lease Financing Chart

Fifty 1 Labs Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Fifty 1 Labs Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Fifty 1 Labs Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $ Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Lease Financing of $ Mil mean?
Fifty 1 Labs (FITY) has a Cash Flow for Lease Financing of $ Mil as of Mar. 2026. Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing. View historical data on Fifty 1 Labs and its competitors.
Is Fifty 1 Labs' Cash Flow for Lease Financing too high?
Fifty 1 Labs' current Cash Flow for Lease Financing is $ Mil.
How does Fifty 1 Labs' Cash Flow for Lease Financing compare to GRPS and KOAN?
Fifty 1 Labs' Cash Flow for Lease Financing of $ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Lease Financing for a Drug Manufacturers company?
A good Cash Flow for Lease Financing depends on the Drug Manufacturers industry context. However, Cash Flow for Lease Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Lease Financing mean?
A high Cash Flow for Lease Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing. View historical data on Fifty 1 Labs and its competitors. Fifty 1 Labs's current Cash Flow for Lease Financing is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fifty 1 Labs stock overvalued right now?
Fifty 1 Labs (FITY) has a current Cash Flow for Lease Financing of $ Mil. The current Cash Flow for Lease Financing is $ Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Lease Financing calculated?
Cash Flow for Lease Financing is calculated from a company's financial statements. For Fifty 1 Labs (FITY), the current Cash Flow for Lease Financing is $ Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Fifty 1 Labs Business Description

Address 1505 West 2nd Avenue, Suite 506, Melbourne, FL, USA, V6J 1H2
Fifty 1 Labs Inc. is a U.S. holding company whose subsidiaries operate in the sports supplement, fitness equipment, and health and wellness markets. Its supplement line includes pre-workout formulas, BCAAs, an electrolyte product marketed as ION+, and gummies containing turmeric and ashwagandha, positioned for athletic performance, recovery, and general wellness. The company sells primarily through online and e-commerce channels, targeting fitness enthusiasts, athletes, and health-conscious consumers, mainly in the United States. Revenue is generated through direct product sales of supplements and related fitness and wellness goods, with the holding company structure allowing it to pursue acquisitions and brand expansion across its segments.